TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.40$ +0.0% vs. previous close Closing price · As of: Sep 11, 2026

Ownership

Ownership Structure

Who owns AtaiBeckley Inc. (ATAI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.2% of the shares are freely tradable; institutional investors hold 44.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 44.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 83.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 371Mio.

Largest Shareholders

Institutions

Institutions ATAI
Name Stake (%) Shares Change (%) Date
BlackRock Inc 6.91 25,574,573 +274.2 06/30/2026
Deep Track Capital, LP 3.90 14,417,442 +20.1 06/30/2026
Vanguard Capital Management, LLC 3.18 11,747,249 -0.1 06/30/2026
State Street Corp 2.24 8,287,054 +624.2 06/30/2026
Geode Capital Management, LLC 1.87 6,933,309 +176.2 06/30/2026
Adage Capital Partners Gp LLC 1.53 5,642,758 +0.0 06/30/2026
UBS Group AG 1.20 4,424,701 -40.4 06/30/2026
Vanguard Portfolio Management, LLC 1.11 4,106,450 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 1.04 3,852,772 +0.0 03/31/2026

Funds

Funds ATAI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.49 9,198,265 -0.2 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 11, 2026 Craig Kevin James Chief Medical Officer Other 8,437 – –
Sep 11, 2026 Rao Srinivas See remarks Other 3,500 – –
Sep 11, 2026 Rao Srinivas See remarks Other 212,942 – –
Sep 11, 2026 Johnson Anne Nagengast Chief Accounting Officer Other 140,045 – –
Sep 11, 2026 Barrett Christopher Ryan Cave See remarks Other 155,066 – –
Sep 11, 2026 Short Glenn Frank Chief Scientific Officer Other 42,333 – –
Sep 11, 2026 Kalali Amir H Director Other 4,666 – –
Sep 11, 2026 Smiley Andrea Heslin Director Other 4,666 – –
Sep 11, 2026 Angermayer Christian Director Other 1,799,302 – –
Sep 11, 2026 Angermayer Christian Director Other 53,398,214 – –
Sep 11, 2026 Angermayer Christian Director Other 559,232 – –
Apr 20, 2026 Kevin James Craig Insider Sell 42,579 5.00 212,895

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?